Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.10.5027

Expression of Survivin and Caspase 3 in Oral Squamous Cell Carcinoma and Peritumoral Tissue  

Li, S.X. (School of Stomatology, Capital Medical University)
Chai, L. (Faculty of Dentistry, The University of Hong Kong)
Cai, Z.G. (School of Stomatology, Peking University)
Jin, L.J. (Faculty of Dentistry, The University of Hong Kong)
Chen, Y. (School of Stomatology, Peking University)
Wu, H.R. (School of Stomatology, Capital Medical University)
Sun, Z. (School of Stomatology, Capital Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.10, 2012 , pp. 5027-5031 More about this Journal
Abstract
This study was conducted to investigate the expression of survivin and caspase 3 in oral squamous cell carcinoma and peritumoral tissue, and possible pathogenesis mechanisms. We used ELISA and western blotting to detect the protein expression levels of survivin and caspase 3 in tissue. In situ hybridization and real-time PCR were applied to assess mRNA expression levels. In this study, 13 tumor samples and 13 peritumoral tissue samples were collected from oral squamous cell carcinoma patients and 10 normal tissue samples obtained from patients without tumor. The result showed that the protein and mRNA expression of survivin in carcinoma was the highest among three types of tissue; following was that in peritumoral tissue. No difference in caspase 3 zymogen between peritumoral tissue and normal tissue could be found, while it was evidently decreased in carcinoma tissue. Activated caspase 3 was detected in normal tissue but could not be identified in peritumoral or carcinoma tissue. Our results indicate that the expression of survivin is apparently elevated in tumoral and peritumoral tissue. Expression of activated caspase 3 was not detected in tumoral tissue and the expression of caspase 3 zymogen was decreased in tumoral tissue. Our findings suggest that survivin may inhibit both synthesis and activation of caspase 3, hence inhibiting cell apoptosis and facililitating eventual development of oral squamous cell carcinoma.
Keywords
Survivin; caspase 3; oral squamous cell carcinoma; apoptosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bursch W, Karwan A, Mayer M, et al (2008). Cell death and autophagy: cytokines, drugs, and nutritional factors. Toxicology, 254, 147-57.   DOI
2 De Maria S, Pannone G, Bufo P, et al (2009). Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol, 135, 107-16.   DOI
3 Fraunholz I, Rodel C, Distel L, et al (2012). High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy. Radiat Oncol, 7, 88.   DOI
4 Gibson S, Shillitoe EJ(2006). Analysis of apoptosis-associated genes and pathways in oral cancer cells. J Oral Pathol Med, 35, 146-54.   DOI
5 Gomes TS, Oshima CT, Segreto HR, et al (2011). The extrinsic apoptotic signaling pathway in gastric adenocarcinomas assessed by tissue microarray. Pathol Res Pract, 207, 613-7.   DOI
6 Grutter MG (2000). Caspases: key players in programmed cell death. Curr Opin Struct Biol, 10, 649-55.   DOI   ScienceOn
7 Halasova E, Adamkov M, Matakova T, et al (2012). Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma. Adv Exp Med Biol, 756, 15-21.
8 Kanwar JR, Kamalapuram SK, Kanwar RK (2012). Survivin Signaling in Clinical Oncology: A Multifaceted Dragon. Med Res Rev. doi: 10.1002/med.21264.   DOI
9 Khan Z, Tiwari RP, Mulherkar R, et al (2009). Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Head Neck, 31, 1039-48.   DOI
10 Kim WH, Yeo M, Kim MS, et al (2000). Role of caspase-3 in apoptosis of colon cancer cells induced by nonsteroidal anti-inflammatory drugs. Int J Colorectal Dis, 15, 105-11.   DOI
11 Sica G, Lama G, Anile C, et al (2011). Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma. Int J Oncol, 38, 41-9.
12 Span PN, Tjan-Heijnen VC, Manders P, et al (2006). High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Breast Cancer Res Treat, 98, 223-30.   DOI
13 Suzuki A, Hayashida M, Ito T, et al (2000). Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene, 19, 3225-34.   DOI
14 Suzuki A, Ito T, Kawano H, et al (2000). Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene, 19, 1346-53.   DOI
15 Tamm I, Kornblau SM, Segall H, et al (2000). Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res, 6, 1796-803.
16 Waligorska-Stachura J, Jankowska A, Wasko R, et al (2012). Survivin-- prognostic tumor biomarker in human neoplasms--review. Ginekol Pol, 83, 537-40.
17 Yu JQ, Bao W, Lei JC (2012). Emodin regulates apoptotic pathway in human liver cancer cells. Phytother Res. doi:10.1002/ptr.4703.   DOI
18 Zhang LQ, Wang J, Jiang F, et al (2012). Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis. PLoS One, 7, e34100.   DOI
19 Zheng WE, Chen H, Yuan SF, et al (2012). Overexpression of ${\beta}$III-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer. J BUON, 17, 284-90.
20 Blanc C, Deveraux QL, Krajewski S, et al (2000). Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res, 60, 4386-90.
21 Ko SY, Dass CR, Nurgali K (2012). Netrin-1 in the developing enteric nervous system and colorectal cancer. Trends Mol Med, 18, 544-54.   DOI
22 Li J, Chen P, Li XQ, et al (2012). Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer. Int J Cancer. doi: 10.1002/ijc.27757.   DOI
23 Loncarevic S, Vignjevic S, Jovic N, et al (2012). Significance of pathohistological findings and the expression of Bcl-2 in diagnosis and treatment of oral planocellular carcinoma. Vojnosanit Pregl, 69, 314-9.   DOI
24 Malaguarnera R, Morcavallo A, Belfiore A (2012). The insulin and igf-I pathway in endocrine glands carcinogenesis. J Oncol, 2012, 635614.
25 Mangiola A, Lama G, Giannitelli C, et al (2008). Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Clin Cancer Res, 13, 6970-7.
26 McKenzie JA, Grossman D (2012). Role of the apoptotic and mitotic regulator survivin in melanoma. Anticancer Res, 32, 397-404.
27 Preuss SF, Weinell A, Molitor M, et al (2008). Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma. Head Neck, 30, 1318-24.   DOI
28 Ryan BM, Konecny GE, Kahlert S, et al (2006). Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol, 17, 597-604.   DOI
29 Seol JG, Park WH, Kim ES, et al (2001). Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells. Int J Oncol, 18, 249-55.